Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Edwards Lifesciences, Intel, Rosetta, Vulcan: U.S. Equity Movers

Dec. 12 (Bloomberg) -- Shares of the following companies had unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York.

Financial shares retreated as Moody’s Investors Service said it will review the ratings of all European Union countries.

Bank of America Corp. (BAC US) declined 4.7 percent, the most in the Dow Jones Industrial Average, to $5.45. JPMorgan Chase & Co. (JPM US) fell 3.4 percent to $32.04. Morgan Stanley (MS US) slipped 6.1 percent to $15.38. Citigroup Inc. (C US) dropped 5.4 percent to $27.22.

Cheniere Energy Inc. (LNG US) jumped 5.5 percent to $10.04, the highest price since Nov. 30. Gail India Ltd. (GAIL IN) agreed to buy 3.5 million metric tons of liquefied natural gas a year for two decades from the Houston-based liquefied-natural-gas company.

Diamond Foods Inc. (DMND US) fell the most since its initial public offering in July 2005, sliding 23 percent to $31.30. The snack maker, which is undergoing an internal probe into whether money paid to walnut growers violated accounting rules, fell after the Wall Street Journal reported that some farmers questioned explanations of payments. Paul Kranhold, an outside spokesman for Diamond, said the payments were confidential and the company wouldn’t comment further.

Edwards Lifesciences Corp. (EW US) climbed 5.1 percent, the most since Oct. 20, to $67.85. The maker of products to treat late-stage cardiovascular disease was raised to “buy” from “hold” at Canaccord Genuity Corp., which cited a “robust” product pipeline and a better-than-expected 2012 forecast from management.

Endo Pharmaceuticals Holdings Inc. (ENDP US) rose 6 percent to $36.04, the highest price since Aug. 1. The drugmaker said the U.S. Food and Drug Administration approved a new formulation for its crush-resistant Opana painkiller.

Fuelcell Energy Inc. (FCEL US) jumped 15 percent, the most since Sept. 7, to $1.09. The maker of low-pollution power plants agreed to partner with Abengoa SA to develop localized stationary fuel cell power plants for Europe and Latin America.

Intel Corp. (INTC US) dropped the most since Aug. 18, erasing 4 percent to $24. The world’s largest maker of semiconductors cut its forecast for fourth-quarter revenue, saying supply shortages for hard drives are prompting computer producers to cut orders for other components.

Applied Materials Inc. (AMAT US), the largest producer of chipmaking equipment, fell 6.1 percent to $10.52.

Onyx Pharmaceuticals Inc. (ONXX US) tumbled 4 percent, the most since Nov. 1, to $39. The pharmaceutical company’s experimental cancer drug carfilzomib will get a standard review from U.S. regulators, instead of an accelerated process sought by the company. The Food and Drug Administration said the company hadn’t conducted the clinical trials necessary for the quicker review.

Rosetta Resources Inc. (ROSE US) fell 12 percent, the most since March 2009, to $44.66. The oil and natural gas producer had its share-price estimate cut to $53 from $55 by Howard Weil Inc., which said the company’s planned capital spending for next year is “much higher than we expected.”

Salesforce.com Inc. (CRM US) slipped 6.3 percent, the most since Nov. 18, to $116.07. The largest maker of online customer-management software was cut to “underperform” from “neutral” at Cowen & Co. LLC.

Vulcan Materials Co. (VMC US) rallied 15 percent to $38.70 for the biggest increase in the Standard & Poor’s 500 Index. Martin Marietta Materials Inc. (MLM US), a supplier of crushed stone, offered to buy the producer of construction aggregates, asphalt mix and concrete for about $36.69 a share, or $4.7 billion.

To contact the reporters on this story: Lu Wang in New York at lwang8@bloomberg.net.

To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.